NRX Pharmaceuticals (NRXP) Tax Rate (2018 - 2024)
NRX Pharmaceuticals' (NRXP) quarterly Tax Rate came in at 0.12% in Q4 2024, up 224.22% quarter-over-quarter from 0.1% in Q3 2024.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Tax Rate (2018 - 2024) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Tax Rate for 4 consecutive years, with 0.12% the latest figure, recorded in Q4 2024.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 0.12% in Q4 2024; TTM through Sep 2025 was 0.02%, a 4.0% increase from a year earlier, with the FY2024 full-year figure at 288.6%, down 13971.0% from the prior year.
- Tax Rate was 0.12% for Q4 2024 at NRX Pharmaceuticals, up from 0.1% in the prior quarter.
- Over five years, Tax Rate peaked at 21.0% in Q1 2020 and troughed at 6.59% in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | NRX Pharmaceuticals | 127.63 Mn | 100.93 Mn | 426,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.12% |
| Sep 30, 2024 | -0.10% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | 0.83% |
| Jun 30, 2020 | -6.59% |
| Mar 31, 2020 | 21.00% |
| Dec 31, 2019 | -76.05% |
| Sep 30, 2019 | 21.00% |
| Jun 30, 2019 | 18.77% |
| Mar 31, 2019 | 14.44% |
| Sep 30, 2018 | 56.52% |
| Jun 30, 2018 | 59.53% |
| Mar 31, 2018 | 21.00% |